Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nicolas Deblon"'
Autor:
Christelle Veyrat-Durebex, Nicolas Deblon, Aurélie Caillon, Ruth Andrew, Jordi Altirriba, Alex Odermatt, Françoise Rohner-Jeanrenaud
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34002 (2012)
Glucocorticoids (GCs) are involved in multiple metabolic processes, including the regulation of insulin sensitivity and adipogenesis. Their action partly depends on their intracellular activation by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1
Externí odkaz:
https://doaj.org/article/abb3e609a9ad47899244a96f520f4323
Autor:
Nicolas Deblon, Christelle Veyrat-Durebex, Lucie Bourgoin, Aurélie Caillon, Anne-Lise Bussier, Stefania Petrosino, Fabiana Piscitelli, Jean-Jacques Legros, Vincent Geenen, Michelangelo Foti, Walter Wahli, Vincenzo Di Marzo, Françoise Rohner-Jeanrenaud
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e25565 (2011)
Apart from its role during labor and lactation, oxytocin is involved in several other functions. Interestingly, oxytocin- and oxytocin receptor-deficient mice develop late-onset obesity with normal food intake, suggesting that the hormone might exert
Externí odkaz:
https://doaj.org/article/a03d7f3e041a4d24986bb809857da0a3
Autor:
Sarah Garrido-Urbani, Françoise Rohner-Jeanrenaud, Jordi Altirriba, Anne-Laure Poher, Patricia Ropraz, Nicolas Deblon, Aurélie Caillon
Publikováno v:
Diabetes & Metabolism (2017)
Aim Oxytocin administration to diet-induced obese (DIO) rodents, monkeys and humans decreases body weight and fat mass with concomitant improvements in glucose metabolism. Moreover, several studies show an immunomodulatory role of oxytocin in a numbe
Autor:
Paul T. Pfluger, Martine Laville, Françoise Rohner-Jeanrenaud, Emmanuel Disse, Nicolas Deblon, Anne-Lise Bussier, Matthias H. Tschöp
Publikováno v:
Physiology & Behavior, Vol. 102, No 5 (2011) pp. 481-4
Physiology and Behavior
Physiology and Behavior, Elsevier, 2011, 102 (5), pp.481-484. ⟨10.1016/j.physbeh.2010.12.006⟩
Physiology and Behavior
Physiology and Behavior, Elsevier, 2011, 102 (5), pp.481-484. ⟨10.1016/j.physbeh.2010.12.006⟩
International audience; Aims: Ghrelin is one of the most potent orexigens known to date. Recent data suggested that ghrelin is involved in reward-mediated processes such as the rewarding value of food. Whereas the neuronal pathways by which ghrelin r
Autor:
Anne-Lise Bussier, Walter Wahli, Jean-Jacques Legros, Lucie Bourgoin, Michelangelo Foti, Stefania Petrosino, Vincent Geenen, Fabiana Piscitelli, Vincenzo Di Marzo, Françoise Rohner-Jeanrenaud, Christelle Veyrat-Durebex, Aurélie Caillon, Nicolas Deblon
Publikováno v:
PloS one
PLoS One, vol. 6, no. 9, pp. e25565
PLoS ONE, Vol 6, Iss 9, p e25565 (2011)
PLoS ONE
PLOS ONE, Vol. 6, No 9 (2011) P. e25565
PLoS One
PloS one 6 (2011): 25565.
info:cnr-pdr/source/autori:Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Piscitelli F, Legros JJ, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud F./titolo:Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats./doi:/rivista:PloS one/anno:2011/pagina_da:25565/pagina_a:/intervallo_pagine:25565/volume:6
PLoS One, vol. 6, no. 9, pp. e25565
PLoS ONE, Vol 6, Iss 9, p e25565 (2011)
PLoS ONE
PLOS ONE, Vol. 6, No 9 (2011) P. e25565
PLoS One
PloS one 6 (2011): 25565.
info:cnr-pdr/source/autori:Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Piscitelli F, Legros JJ, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud F./titolo:Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats./doi:/rivista:PloS one/anno:2011/pagina_da:25565/pagina_a:/intervallo_pagine:25565/volume:6
Apart from its role during labor and lactation, oxytocin is involved in several other functions. Interestingly, oxytocin- and oxytocin receptor-deficient mice develop late-onset obesity with normal food intake, suggesting that the hormone might exert
Autor:
Jordi Altirriba, Françoise Rohner-Jeanrenaud, Ruth Andrew, Aurélie Caillon, Nicolas Deblon, Christelle Veyrat-Durebex, Alex Odermatt
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34002 (2012)
Veyrat-Durebex, C, Deblon, N, Caillon, A, Andrew, R, Altirriba, J, Odermatt, A & Rohner-Jeanrenaud, F 2012, ' Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue ', PLoS ONE, vol. 7, no. 3, pp. e34002 . https://doi.org/10.1371/journal.pone.0034002
PLOS ONE, Vol. 7, No 3 (2012) P. e34002
PloS one
PLoS ONE
Veyrat-Durebex, C, Deblon, N, Caillon, A, Andrew, R, Altirriba, J, Odermatt, A & Rohner-Jeanrenaud, F 2012, ' Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue ', PLoS ONE, vol. 7, no. 3, pp. e34002 . https://doi.org/10.1371/journal.pone.0034002
PLOS ONE, Vol. 7, No 3 (2012) P. e34002
PloS one
PLoS ONE
Glucocorticoids (GCs) are involved in multiple metabolic processes, including the regulation of insulin sensitivity and adipogenesis. Their action partly depends on their intracellular activation by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1
Autor:
Matthias H. Tschöp, Françoise Rohner-Jeanrenaud, Martine Laville, Emmanuel Disse, Christelle Veyrat-Durebex, Anne-Lise Bussier, Nicolas Deblon, Paul T. Pfluger
Publikováno v:
Physiology & Behavior, Vol. 101, No 2 (2010) pp. 277-281
Aims Ghrelin is one of the most potent orexigens known to date. While the prevailing view is that ghrelin participates in the homeostatic control of feeding, the question arose as to whether consummatory responses evoked by this compound could be rel
Autor:
José Adélaïde, Guoqiang Hua, Daniel Birnbaum, Frédéric M. Rosa, Bing Zhu, Jean Imbert, Brigitte Kahn-Perlès, Nicolas Deblon
Publikováno v:
Molecular cancer research : MCR. 7(3)
Overexpression of the ERBB2 gene, linked to genomic and transcriptional amplifications, is a poor prognosis indicator in 25% to 30% of breast cancers. In contrast to some well-documented genomic amplifications, molecular mechanisms leading to ERBB2 t
Autor:
Jean-Jacques Legros, Vincent Geenen, Lucie Bourgoin, Françoise Rohner-Jeanrenaud, Aurélie Caillon, Anne-Lise Bussier, Christelle Veyrat-Durebex, Michelangelo Foti, Walter Wahli, V. Di Marzo, Nicolas Deblon
Publikováno v:
Diabetes & Metabolism. 37:A8-A9
Introduction L’oxytocine (OT) est une hormone neurohypophysaire impliquee dans de nombreux processus biologiques. Parmi ceux-ci, il a ete montre que l’OT inhibe la prise alimentaire. De plus, les souris deficientes pour le gene codant pour l’OT